DNA methylation profiling of cervical squamous intraepithelial lesions using liquid-based cytology specimens
- 14 July 2004
- Vol. 102 (4) , 259-268
- https://doi.org/10.1002/cncr.20425
Abstract
BACKGROUND Cervical carcinoma is a common malignancy among women worldwide, and its pathogenesis is related causally to human papillomavirus infection. The progression from precursor squamous intraepithelial lesions to cervical carcinoma requires additional genetic and epigenetic alterations that have not been characterized fully. The authors examined aberrant promoter methylation of multiple tumor suppressor genes in precursor squamous intraepithelial lesions. METHODS A multiplex, nested, methylation‐specific polymerase chain reaction approach was used to examine promoter methylation of 15 tumor suppressor genes in high‐grade squamous intraepithelial lesions (HSIL, n = 11), low‐grade squamous intraepithelial lesions (LSIL, n = 17), and negative tissues (n = 11) from liquid‐based cytology samples. The area under the receiver‐operating characteristic (ROC) curve was determined for individual methylated tumor suppressor genes and for gene combinations to evaluate test performance for the ability of methylation profiles to distinguish HSIL cytology samples from combined LSIL/negative cytology samples. RESULTS Aberrant promoter methylation of DAPK1 and IGSF4 occurred at a high frequency in HSIL samples and was absent in LSIL and negative samples. There was a significant trend toward increased methylation with the increased severity of lesions, and the mean number of methylated genes was significantly higher in HSIL samples compared with LSIL and negative samples. Using the area under the ROC curve as a measure of test performance, the methylation of IGSF4 and DAPK1 had areas that were significantly greater than 0.5; thus, each had the ability to distinguish HSIL samples from combined LSIL/negative samples. The areas under the curve for the best two‐gene combination (IGSF4/DAPK1) and the best three‐gene combination (IGSF4/DAPK1/HIC1) were not statistically different from the best individual tumor suppressor gene (IGSF4) in distinguishing HSIL samples from combined LSIL/negative samples. CONCLUSIONS Aberrant promoter methylation of tumor suppressor genes is an epigenetic alteration that occurs during neoplastic progression to cervical carcinoma. The methylation status of multiple tumor suppressor genes can be evaluated using ROC analysis to determine methylation profiles that can distinguish HSIL samples from combined LSIL/negative samples. Cancer (Cancer Cytopathol) 2004. © 2004 American Cancer Society.Keywords
This publication has 25 references indexed in Scilit:
- TSLC1 Gene Silencing in Cervical Cancer Cell Lines and Cervical NeoplasiaJNCI Journal of the National Cancer Institute, 2004
- Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976–2000Cancer, 2004
- Human Papillomavirus: Epidemiology and Public HealthArchives of Pathology & Laboratory Medicine, 2003
- Frequent Promoter Methylation of CDH1, DAPK, RARB, and HIC1 Genes in Carcinoma of Cervix Uteri: Its Relationship to Clinical OutcomeMolecular Cancer, 2003
- The causal relation between human papillomavirus and cervical cancerJournal of Clinical Pathology, 2002
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Estimates of the world‐wide prevalence of cancer for 25 sites in the adult populationInternational Journal of Cancer, 2001
- The Rising Incidence of Adenocarcinoma Relative to Squamous Cell Carcinoma of the Uterine Cervix in the United States—A 24-Year Population-Based StudyGynecologic Oncology, 2000
- In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesisProceedings of the National Academy of Sciences, 1999
- The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteriObstetrics & Gynecology, 1995